Loading live market data…

Enliven Therapeutics, Inc.

NASDAQ:ELVN

$53.16 USD

$1.43 (2.76%)

Volume
495.49K
Average Volume
1.33M
Market Capitalization
$3.8B
P/E Ratio
-32.41
Dividend Yield
0.00%
Price Target
$65.00
Year High
$53.24
Year Low
$14.79
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$40.32

ELVN Estimated and Actual Revenue by Quarter

ELVN Estimated and Actual EPS by Quarter

ELVN Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -45.84M -45.84M -45.84M - - -
2027-09-30 0 -41.76M -41.76M -41.76M - - -
2027-06-30 0 -38.31M -38.31M -38.31M - - -
2027-03-31 0 -34.12M -34.12M -34.12M - - -
2026-12-31 0 -32.55M -32.55M -32.55M - - -
2026-09-30 0 -27.37M -26.68M -27.37M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.73 -0.73 -0.73
2027-09-30 0 - - - 1 -0.665 -0.665 -0.665
2027-06-30 0 - - - 1 -0.61 -0.61 -0.61
2027-03-31 0 - - - 1 -0.54333 -0.54333 -0.54333
2026-12-31 0 - - - 1 -0.51825 -0.51825 -0.51825
2026-09-30 0 - - - 2 -0.43576 -0.42487 -0.43576